13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001166309
Total reported value
$150.1M
$150.1M
28 檔
56.8%
During the Q4 2024 filing period, Bridger Management, LLC (CIK: 0001166309) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $150.1M across 28 reported positions.
Bridger Management, LLC executed strategic sector rebalancing during Q4 2024, establishing 4 new positions while fully exiting 5 holdings and trimming 4 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MS | Morgan Stanley | Stock-Financials | 12.68% | +1.20% | — | |
| 2 | UBER | Uber Technologies Inc | Stock-Industrials | 9.38% | -0.47% | -3.98% | |
| 3 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 8.88% | — | — | |
| 4 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 8.23% | -0.35% | -29.15% | |
| 5 | PFE | Pfizer Inc | Stock-Healthcare | 6.64% | — | +32.97% | |
| 6 | WYNN | Wynn Resorts LTD | Stock-Consumer Disc | 6.26% | — | +34.92% | |
| 7 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 5.21% | — | +11.24% | |
| 8 | BBWI | Bath & Body Works Inc | Stock-Consumer Disc | 5.20% | — | +12.49% | |
| 9 | ZBH | Zimmer Biomet Holdings Inc | Stock-Healthcare | 5.14% | — | — | |
| 10 | BLCO | Bausch + Lomb CORP | Stock-Other | 4.91% | — | — | |
| 11 | GMAB | Genmab A/s -sp Adr | Stock-Other | 3.27% | — | — | |
| 12 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 3.09% | — | — | |
| 13 | IBIT | Ishares Bitcoin Trust ETF | ETF-Crypto | 3.08% | -0.66% | — | |
| 14 | SWTXUSD | Springworks Therapeutics Inc | Stock-Other | 2.81% | — | — | |
| 15 | CZR | Caesars Entertainment Inc | Stock-Consumer Disc | 2.65% | — | — | |
| 16 | GERN | Geron CORP | Stock-Other | 2.55% | — | — | |
| 17 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 1.43% | -0.25% | +66.77% | |
| 18 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 1.41% | +0.25% | — | |
| 19 | MLCO | Melco Resorts & Entert-adr | Stock-Other | 1.10% | -0.48% | -63.96% | |
| 20 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 1.07% | — | — | |
| 21 | QTRX | Quanterix CORP | Stock-Other | 1.06% | — | +19.49% | |
| 22 | TOST | Toast Inc-class A | Stock-Tech | 1.03% | -0.09% | — | |
| 23 | MSFT | Microsoft CORP | Stock-Tech | 0.96% | -0.50% | — | |
| 24 | MA | Mastercard Inc - A | Stock-Financials | 0.68% | — | — | |
| 25 | HOOD | Robinhood Markets Inc - A | Stock-Financials | 0.53% | — | — | |
| 26 | GDX | Vaneck Gold Miners ETF | ETF-Commodities | 0.46% | — | -87.01% | |
| 27 | NEXT | Nextdecade CORP | Stock-Other | 0.28% | -0.07% | — | |
| 28 | SRZNW | Surrozen Inc-cw25 | Stock-Other | 0.01% | -0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ZBH | Zimmer Biomet Holdings Inc | +5.1% | NEW | New buy |
| 2 | GMAB | Genmab A/s -sp Adr | +3.3% | NEW | New buy |
| 3 | MS | Morgan Stanley | +2.9% | — | Unchanged |
| 4 | BBWI | Bath & Body Works Inc | +1.7% | +12.49% | Add |
| 5 | PFE | Pfizer Inc | +1.6% | +32.97% | Add |
| 6 | WYNN | Wynn Resorts LTD | +1.5% | +34.92% | Add |
| 7 | IBIT | Ishares Bitcoin Trust ETF | +1.1% | — | Unchanged |
| 8 | AMZN | Amazon.com Inc | +0.8% | +66.77% | Add |
| 9 | MA | Mastercard Inc - A | +0.7% | NEW | New buy |
| 10 | HOOD | Robinhood Markets Inc - A | +0.5% | NEW | New buy |
| 11 | SWTXUSD | Springworks Therapeutics Inc | +0.5% | — | Unchanged |
| 12 | TOST | Toast Inc-class A | +0.3% | — | Unchanged |
| 13 | GOOGL | Alphabet Inc-cl A | +0.3% | — | Unchanged |
| 14 | XENE | Xenon Pharmaceuticals Inc | +0.2% | — | Unchanged |
| 15 | ALNY | Alnylam Pharmaceuticals Inc | +0.1% | +11.24% | Add |
| 16 | NEXT | Nextdecade CORP | +0.1% | — | Unchanged |
| 17 | EWTX | Edgewise Therapeutics Inc | +0.1% | — | Unchanged |
| 18 | QTRX | Quanterix CORP | +0.1% | +19.49% | Add |
| 19 | MSFT | Microsoft CORP | +0.1% | — | Unchanged |
| 20 | BLCO | Bausch + Lomb CORP | 0% | — | Unchanged |
| 21 | SRZNW | Surrozen Inc-cw25 | 0% | — | Unchanged |
| 22 | CZR | Caesars Entertainment Inc | -0.4% | — | Unchanged |
| 23 | GERN | Geron CORP | -0.5% | — | Unchanged |
| 24 | 430 | Terns Pharmaceuticals Inc | -0.6% | EXIT | Sold out |
| 25 | TEVA | Teva Pharmaceutical-sp Adr | -0.6% | -29.15% | Trim |
| 26 | VRTX | Vertex Pharmaceuticals Inc | -0.7% | — | Unchanged |
| 27 | SVRA | Savara Inc | -0.8% | EXIT | Sold out |
| 28 | CPRX | Catalyst Pharmaceuticals Inc | -0.9% | EXIT | Sold out |
| 29 | UBER | Uber Technologies Inc | -2% | -3.98% | Trim |
| 30 | MLCO | Melco Resorts & Entert-adr | -2.7% | -63.96% | Trim |
| 31 | GDX | Vaneck Gold Miners ETF | -3.4% | -87.01% | Trim |
| 32 | BMY | Bristol-myers Squibb Co | -3.8% | EXIT | Sold out |
| 33 | OSCR | Oscar Health Inc - Class A | -4.4% | EXIT | Sold out |
According to official SEC Form 13F filings, Bridger Management, LLC reported a total U.S. public equity portfolio value of $150.1M across 28 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including MS, UBER, VRTX) accounted for 56.8% of total reported equity market value during Q4 2024.
Top New Position Initiated
ZBH
市值: $9.6M
Top Position Liquidated / Trimmed
OSCR
前期市值: $8.8M
During Q4 2024, Bridger Management, LLC's top holdings by market value included MS (12.7%)、UBER (9.4%)、VRTX (8.9%). The largest single position, MS, represented 12.7% of total portfolio value.
In Q4 2024, Bridger Management, LLC made 19 total portfolio adjustments, initiating 4 new buys, adding to 6 positions, trimming 4 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.